Lactate oxidase nanocapsules boost T cell immunity and efficacy of cancer immunotherapy
Science Translational Medicine · 11.10.2023 · 15 (717)
DOI: 10.1126/scitranslmed.add2712 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 11.10.2023. Verfasst von Zheng Cao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, University of California Los Angeles, Los Angeles, CA 90095, USA. Hauptthemen laut MEDLINE: Nanocapsules, Melanoma. Die Arbeit wurde bisher 141-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Cancer immunotherapy has reshaped the landscape of cancer treatment. However, its efficacy is still limited by tumor immunosuppression associated with the excessive production of lactate by cancer cells. Although extensive efforts have been made to reduce lactate concentrations through inhibition of lactate dehydrogenase, such inhibitors disrupt the metabolism of healthy cells, causing severe nonspecific toxicity. We report herein a nanocapsule enzyme therapeutic based on lactate oxidase, which reduces lactate concentrations and releases immunostimulatory hydrogen peroxide, averting tumor immunosuppression and improving the efficacy of immune checkpoint blockade treatment. As demonstrated in a murine melanoma model and a humanized mouse model of triple-negative breast cancer, this enzyme therapeutic affords an effective tool toward more effective cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Biomolecular Engineering, University of California Los Angeles, Los Angeles, CA 90095, USA.
- UCLA AIDS Institute, University of California Los Angeles, Los Angeles, CA 90095, USA.
- Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, Los Angeles, CA 90095, USA.
- Division of Nanomedicine, Department of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.
- Beijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University of Chemical Technology, Beijing 100029, China.
- Changping Laboratory, Beijing 100871, China.
ORCID-Profile: Zheng Cao, Duo Xu, Xiangsheng Liu, Irvin S Y Chen, Jimin Guo, Yunfeng Lu, Jing Wen
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Cao, Z., Xu, D., Harding, J., Chen, W., Liu, X., Wang, Z., Wang, L., Qi, T., Chen, S., Guo, X., Chen, I. S. Y., Guo, J., Lu, Y., & Wen, J. (2023). Lactate oxidase nanocapsules boost T cell immunity and efficacy of cancer immunotherapy. Science Translational Medicine, 15(717). https://doi.org/10.1126/scitranslmed.add2712
Vancouver
Cao Z, Xu D, Harding J, Chen W, Liu X, Wang Z, et al. Lactate oxidase nanocapsules boost T cell immunity and efficacy of cancer immunotherapy. Science Translational Medicine. 2023;15(717). doi:10.1126/scitranslmed.add2712
BibTeX
@article{Cao2023,
author = {Cao, Zheng and Xu, Duo and Harding, Jeffrey and Chen, Wenting and Liu, Xiangsheng and Wang, Zi and Wang, Lan and Qi, Tong and Chen, Shilin and Guo, Xinheng and Chen, Irvin S Y and Guo, Jimin and Lu, Yunfeng and Wen, Jing},
title = {Lactate oxidase nanocapsules boost T cell immunity and efficacy of cancer immunotherapy},
journal = {Science Translational Medicine},
year = {2023},
volume = {15},
number = {717},
doi = {10.1126/scitranslmed.add2712}
}
EUVIMED